RECRUITINGOBSERVATIONAL
Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Phenotypical Und Functional Characterization of Macrophages in Critically Ill Patients With Pseudomonas Aeruginosa Induced Sepsis
About This Trial
The present study focuses on patients with Pseudomonas aeruginosa (PSA) sepsis. The aim of the present study is to find out whether the M1 (pro-inflammatory) or M2 (anti-inflammatory) phenotype predominates in blood monocytes in critically ill patients with PSA-sepsis, and whether the severity of sepsis and outcome is associated with distinct monocyte phenotype and function.
Who May Be Eligible (Plain English)
Who May Qualify:
- age \> 18 years
- critically ill patients with sepsis
- microbiologically proven infection with Pseudomonas aeruginosa
Who Should NOT Join This Trial:
- life expectancy \< 24 hours
- participation in other studies
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* age \> 18 years
* critically ill patients with sepsis
* microbiologically proven infection with Pseudomonas aeruginosa
Exclusion Criteria:
* life expectancy \< 24 hours
* participation in other studies
Locations (1)
Clinic of Anesthesiology
Ulm, Germany